GLYATL1B: A Potential Drug Target and Biomarker (G100287520)

Target Name: GLYATL1B

NCBI ID: G100287520

GLYATL1B

GLYATL1B: A Potential Drug Target and Biomarker

Glycylated 伪-tubulin (伪-tubulin) is a protein that is synthesized and expressed in various tissues, including muscle, brain, and heart. It is a key component of microtubules, which are dynamic cytoskeletal structures that play a critical role in cell division, transport, and signaling. Glycylated 伪-tubulin has been identified as a potential drug target and biomarker in various diseases, including neurodegenerative disorders, cancer, and cardiovascular diseases.

Glycylated 伪-tubulin is often used as a biomarker to monitor the effectiveness of therapeutic interventions in diseases, such as cancer. 伪-tubulin is expressed in most tissues and is often used as a target for drugs that inhibit its activity. For example, inhibitors of the protein have been shown to reduce the growth of cancer cells and slow down their spread. Additionally, 伪-tubulin has been used as a target for drugs that target microtubules in neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease.

In addition to its potential as a drug target, Glycylated 伪-tubulin is also a potential biomarker for certain diseases. 伪-tubulin is a key component of microtubules, which are dynamic cytoskeletal structures that play a critical role in cell division, transport, and signaling. Its presence and activity can be used to monitor the progression of certain diseases, such as cancer and neurodegenerative disorders. For example, the level of 伪-tubulin in cancer cells is often used as a marker for their sensitivity to certain treatments.

Glycylated 伪-tubulin has also been shown to be involved in various signaling pathways that are involved in disease. For example, it has been shown to be involved in the mitochondrial dysfunction that occurs in neurodegenerative disorders. Additionally, it has been shown to be involved in the regulation of cell adhesion, which is critical for the development and progression of cancer.

In conclusion, Glycylated 伪-tubulin is a protein that has been identified as a potential drug target and biomarker in various diseases. Its activity and presence can be used to monitor the effectiveness of therapeutic interventions and as a biomarker for disease progression. Further research is needed to fully understand the role of Glycylated 伪-tubulin in disease and its potential as a drug target and biomarker.

Protein Name: Glycine-N-acyltransferase Like 1B

Functions: Putative acyltransferase which transfers an acyl group to the N-terminus of glutamine. Can use phenylacetyl-CoA as an acyl donor

The "GLYATL1B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GLYATL1B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets